Nanotechnology: Particle size reduction technologies in the pharmaceutical development process

American Pharmaceutical Review

Volumn 13, Issue 3, 2010, Pages 54-59

  Möschwitzer, Jan ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOCRYSTAL; NANOPARTICLE;

CHEMICAL REACTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; FREEZE DRYING; FREEZING; NANOTECHNOLOGY; PARTICLE SIZE; REVIEW; SPRAY DRYING;

EID: 77951983470     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. P. Gaßmann, M. List, A. Schweitzer and H. Sucker , Hydrosols-alternatives for the parenteral application of poorly water-soluble drugs. Eur. J. Pharm. Biopharm. 40 (1994), pp. 64-72.
2. N. Rasenack, H. Hartenhauer, B. W. Müller; Microcrystals for dissolution rate enhancement of poorly water-soluble drugs; International Journal of Pharmaceutics 254 (2003) 137-145
3. X. Zhang, Q. Xia and N. Gu, Preparation of All-Trans Retinoic Acid Nanosuspensions Using a Modified Precipitation Method, Drug Development and Industrial Pharmacy, 32, 2006, 857-863
4. M. Sarkari, J. Brown, X. Chen, S. Swinnea, Robert O. Williams III, Keith P. Johnston; Enhanced drug dissolution using evaporative precipitation into aqueous solution, International Journal of Pharmaceutics 243 (2002) 17-31
5. J. Hua, K. P. Johnston, R. O. Williams III;Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems, European Journal of Pharmaceutical Sciences 20 (2003) 295-303
6. K. A. Overhoff, J. D. Engstrom, B. Chen, B. D. Scherzer, T. E. Milner, K. P. Johnston, R. O. Williams III; Novel ultra-rapid freezing particle engineering process for enhancement of dissolution rates of poorly water-soluble drugs, European Journal of Pharmaceutics and Biopharmaceutics 65 (2007) 57-67
7. P. York, Strategies for particle design using supercritical fluid technologies, PSTT Vol. 2, No. 11 November 1999, 430-440
8. J. Jung, M. Perrut; Particle design using supercritical fluids: Literature and patent survey, Journal of Supercritical Fluids 20 (2001) 179-219
9. D.W. Maston, J.L. Fulton, R.C. Petersen, and R. D. Smith; Rapid Expansion of Supercritical Fluid Solutions: Solute Formation of Powders, Thin Film, and Fibers, Ind. Eng. Chem. Res. 26, 1987, 2298-2306
10. M. Kim, S. Jin, J. Kim, H. J. Park, H. Song,R. H.H. Neubert, S. Hwang; Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process, European Journal of Pharmaceutics and Biopharmaceutics 69 (2008) 454-465
11. G.G. Liversidge , K.C Cundy, J.F Bishop, D.A Czekai,. Surface modified drug nanoparticles. U.S. Patent 5,145,684, 1992
12. G. G. Liversidge, K. C. Cundy; Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
13. E. Merisko-Liversidge, G. G. Liversidge, E. R. Cooper; Nanosizing: a formulation approach for poorly-water-soluble compounds, European Journal of Pharmaceutical Sciences 18 (2003) 113-120
14. Muller RH, Becker R, Bernd K, Peters K., Pharmaceutical nanosuspensions for medicament administration as systems with increased saturation solubility and speed of dissolution. US Patent, US5,858,410, 1999
15. K. Peters and R.H. Muller; Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size-reduction technique. International Journal of Pharmaceutics, 1998. 160(2): 229-237. (Pubitemid 28083096)
16. R.H Müller,. C. Jacobs, O. Kayser, DissoCubes - A Novel Formulation for Poorly Soluble and Poorly Bioavailable Drugs, in Modified-Release Drug Delivery Technology, M. J. Rathbone, J. Hadgraft, M. S. Roberts, Editors. 2003, Marcel Dekker: New York, Basel. 135-149
17. R.H Muller, K. Krause, and K. Mader, Method for controlled production of ultrafine microparticles and nanoparticles, Application: WO, 2000-EP6535, 2001003670,2001
18. Haynes, D.H., Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs, US 5,091,187;1992
19. A. K. Mishra, M. G. Vachon, P. Guivarc'h, R. S. Snow, G. W. Pace; IDD Technology: Oral Delivery of Water-Insoluble Drugs Using Phospholipid-Stabilized Microparticulate IDD Formulations, in Modified-Release Drug Delivery Technology, M. J. Rathbone, J. Hadgraft, M. S. Roberts, Editors. 2003, Marcel Dekker: New York, Basel. 151-175
20. J.E. Kipp, J.C.T.Wong, M.J.Doty, C.L.Rebbeck, Microprecipitation method for preparing submicron suspensions. US Patent 6,607,784; 2003
21. B.E. Rabinow, Nanosuspensions in drug delivery. Nat Rev Drug Discov, 2004. 3(9), 785-796.
22. J. P. Möschwitzer and R. H Müller, New method for the effective production of ultrafine drug nanocrystals, Journal of Nanoscience and Nanotechnology 2006;6(9-10), 3145-3153
23. J.P. Moeschwitzer, A. Lemke, Method for the gentle production of ultrafine particle suspensions, Germany, DE 10 2005 017 777.8, 2005
24. M. V. Chaubal; Application of formulation technologies in lead candidate selection and optimization, DDT Vol. 9, No. 14 July 2004, 603-609
25. J. Maas, W. Kamm, Gerrit Hauck; An integrated early formulation strategy - From hit evaluation to preclinical candidate profiling, European Journal of Pharmaceutics and Biopharmaceutics 66 (2007) 1-10